Continuous controversy over the issue of the Stillen’s clinical usefulness test… A decision will be made after the review

Through the court’s judgment towards the Dong-A ST’s ‘Stillen’, it will temporarily keep the insurance benefit; however, the ‘Clinical Usefulness Confirmation issue will still have its sore spot exposed.

The Seoul Administrative Court, on the 13^th, ruled of to revoke the Ministry of Health and Welfare’s limitation on the insurance benefit application for the Stillen Tab only with gastritis (ac...